New

First Care Activating Eye Serum 20ml

First Care Activating Eye Serum 20ml

Revitalize tired eyes with Sulwhasoo First Care Activating Eye Serum. Powered by patented LYMPHANAX™ and Ginseng Caffeine™, it’s clinically proven to reduce dark circles by 46% and boost eye area circulation by 67%. Depuff, brighten, and firm with cooling applicator.

First Care Activating Eye Serum 20ml

Total Price

$660

Qty

Add to Wish List

SHIPPING

Free shipping for orders over HK$500. Delivery service only accepts orders shipped within Hong Kong and Macau.

Details

Reviews

FAQ

First Care Activating Eye Serum 20ml,NEW FIRST CARE ACTIVATINGEYE SERUM

VISIBLY REDUCES THE LOOK OF

DARK CIRCLES AND PUFFINESS

_^NEW _{FIRST CARE ACTIVATING}

_{EYE SERUM}

DARK CIRCLES,

_{AREN’T JUST ABOUT BRIGHTNESS}

_{They’re a visible sign that balance of}

_{skin flow, radiance, and firmness}

_{around the eyes has been disrupted}

BOOSTING

To awaken skin vitality

BRIGHTENING

To restore a radiant look

TIGHTENING

To help lift and firm

the eye area

A TRIPLE

DARK CIRCLE SOLUTION

_{THAT PREVENTS ACCELERATED EYE-AREA AGING}

^{BY TARGETING ITS FUNDAMENTAL MECHANISMS}

_{^{SULWHASOO’S PROPRIETARY}}

_{^{ANTI-AGING SAPONIN,}}

LYMPHANAX™

_{LYMPHANAX™, ginseng aged through 500-hour}

^{natural fermentation process, delivers 20 times amplified}

_{anti-aging saponins compared to regular ginseng.}

^{It promotes moisture circulation and activates}

^{skin recovery* to help prevent accelerated aging.}

500

HOURS OF NATURAL

FERMENTATION

TIMES AMPLIFIED

ANTI-AGING SAPONIN

* Recovery of dry and rough skin

ACTIVATEING THE SKIN’S

NATURAL HEALTHY ABILITY

JAUM ACTIVATOR™

^{Formulated with Solomon’s Seal, Peony, Lotus, White Lily,}

^{and Rehmannia as the five key ingredients carefully selected}

^{among thousands of ingredients to consider their synergies,}

^{Sulwhasoo’s patented ingredient JAUM ACTIVATOR™}

^{activates skin’s natural power to fortify skin barrier.}

PREVENTING ACCELERATED SKIN AGING

E.G.R.3 TECHNOLOGY™*

_{Powered by LYMPHANAX™, E.G.R.3 TECHNOLOGY™*}

^{helps activate EGR3*, a key factor of skin function.}

_{Addressing interconnected signs of aging at once,}

^{it helps defend skin against future visible aging.}

_{*EPIDERMAL SKIN SURFACE GRID REBALANCING TECHNOLOGY,}

^{A bio-technology that suppresses accelerated skin aging and helps maintain healthier skin}

STEP 1: BOOSTING

+67.6%*

_{^{Boost skin hydration}}

STEP 2: BRIGHTENING

+46.0%**

_{^{Improvement in the appearance of dark circles}}

STEP 3: TIGHTENING

+26.6%*

_{^{Improvement in under-eye elasticity}}

_{[Clinical study results with product & applicator] Subjects: 33 women ages 25-60,}

^{Test Period: November 17, 2025 – December 22, 2025}

_{* Results after 4 weeks of use}

^{** Self-assessment results after 4 weeks of use}

_^BOOSTING

_{^{Sulwhasoo’s synergistic ingredient that helps}}

_{^{boost moisture circulation around the eyes}}

GINSENG CAFFEINE™

MOISTURE

CIRCULATION

BOOSTING

awakening stagnant flow

around the eyes

_^BRIGHTENING

VISIBLE DARK CIRCLE

IMPROVEMENT

_{^{From the very first use - more noticeable over time}}

BRIGHTENING

-12.6%*

STEP 2: BRIGHTENING

_{Improvement in the appearance}

^{of dark circles}

+46.0%**

STEP 3: TIGHTENING

^{Improvement in under-eye elasticity}

+26.6%*

_{[Clinical study results with product & applicator] Subjects: 33 women ages 25-60,}

^{Test Period: November 17, 2025 – December 22, 2025}

_{1) Results after 4 weeks of use}

^{2) Self-assessment results after 4 weeks of use}

AFTER

1 USE

+8.4%

improvement

AFTER

1 WEEK

+20.9%

improvement

AFTER

1 MONTH

+46.0%

improvement

_{Based on self-assessment results}

_{[Clinical study results with product & applicator] Subjects: 33 women ages 25-60,}

_{Test Period: November 17, 2025 – December 22, 2025}

_^TIGHTENING

For Firmer-Looking Eyes

and Smoother Fine Lines

-12.6%*

Reduction eye bag skin puffiness*

+25.7%**

Improvement in upper eyelid firmness**

+26.6%**

Improvement in under-eye firmness**

* After immediate use ** After 4 weeks of use [Clinical study results with product & applicator] Subjects: 33 women ages 25-60, Test Period: November 17, 2025 – December 22, 2025